MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Cash Flow Overview
Free Cash flow
-$12,815K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Change in fair value of derivati...
Stock-based compensation expense
Depreciation and amortization
Others
Negative Cash Flow Breakdown
Deferred revenue
Prepaid expenses and other curre...
Accrued expenses and other liabi...
Purchases of property and equipm...
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-33,530
-18,331
-40,284
-15,099
Depreciation and amortization
515
520
372
416
Stock-based compensation expense
1,931
1,472
1,151
984
Change in fair value of derivative tranche liability
-20,930
-6,188
-28,030
-1,800
Impairment of right-of-use asset
89
-
0
494
Loss on the sale of property and equipment
-
-
-191
-67
Non-cash gain on lease modification
-
-
316
-
Non-cash lease expense
62
34
480
489
Non-cash interest expense
1
1
-1
1
Prepaid expenses and other current assets
641
-974
779
419
Accounts payable
319
592
-467
-546
Accrued expenses and other liabilities
-453
-1,369
1,198
1,362
Operating lease liabilities
-
-148
782
766
Deferred revenue
-1,780
-1,210
17,500
0
Operating lease liabilities
19
-
-
-
Net cash used in operating activities
-12,686
-10,981
6,293
-11,217
Purchases of property and equipment
129
0
0
0
Proceeds from the sale of property and equipment
-
-
0
36
Net cash used in investing activities
-129
0
0
36
Proceeds from issuance of common stock, net of issuance costs of 3,966 and 5,747, respectively
-
-
57,516
-
Proceeds from issuance of common stock and pre-funded warrants, net
-
-
-
32,562
Proceeds from issuance of pre-funded warrants, net of issuance costs 258
-
-
3,601
-
Proceeds allocated to the derivative tranche liability
-
-
0
14,930
Proceeds from exercise of common stock options
-
-
51
-
Proceeds from exercise of stock options
-
-
-
3
Principal payments on financing obligation
-
0
0
97
Proceeds from exercise of stock options and issuance of common stock under employee stock purchase plan
4
57
-
-
Principal payments on finance leases
0
0
18
14
Payments of deferred issuance costs
-
-
0
0
Net cash provided by (used in) financing activities
4
57
28,585
47,384
Net change in cash, cash equivalents, and restricted cash
-12,811
-10,924
34,878
36,203
Cash, cash equivalents and restricted cash at beginning of period
100,833
111,757
76,879
65,663
Cash, cash equivalents and restricted cash at end of period
88,022
100,833
111,757
76,879
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
CAMP Cash Flow Sankey Diagram
Sankey diagram visualizing CAMP cash flow for the period
Proceeds from exercise of
stock options and...
$4K
Net cash provided by
(used in) financing...
$4K
(105.06%↑ Y/Y)
Net change in cash,
cash equivalents,...
-$12,811K
(48.73%↑ Y/Y)
Canceled cashflow
$4K
Change in fair value of
derivative tranche...
-$20,930K
Stock-based compensation
expense
$1,931K
(3.65%↑ Y/Y)
Depreciation and
amortization
$515K
(-39.48%↓ Y/Y)
Accounts payable
$319K
(2226.67%↑ Y/Y)
Impairment of right-of-use
asset
$89K
Non-cash lease expense
$62K
(-93.50%↓ Y/Y)
Operating lease
liabilities
$19K
Non-cash interest
expense
$1K
(-93.75%↓ Y/Y)
Net cash used in
operating activities
-$12,686K
(48.49%↑ Y/Y)
Net cash used in
investing activities
-$129K
(53.76%↑ Y/Y)
Canceled cashflow
$23,866K
Net loss
-$33,530K
(-34.01%↓ Y/Y)
Purchases of property and
equipment
$129K
(-53.76%↓ Y/Y)
Deferred revenue
-$1,780K
(-362.34%↓ Y/Y)
Prepaid expenses and
other current assets
$641K
(306.77%↑ Y/Y)
Accrued expenses and
other liabilities
-$453K
(74.19%↑ Y/Y)
Buy us a coffee
Camp4 Therapeutics Corp (CAMP)
Camp4 Therapeutics Corp (CAMP)